Gary M. Winer

CIK: 0001822095

Transaction Breakdown

Open Market Buys (P)4 (66.7%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

LNSR

LENSAR, Inc.

Director

HCWB

HCW Biologics Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

LNSR
LENSAR, Inc.
Jun 3, 2026
Award(A)
Direct
17.4K shares-
LNSR
LENSAR, Inc.
May 23, 2025
Award(A)
Direct
7.4K shares-
HCWB
HCW Biologics Inc.
May 16, 2025
Purchase(P)
Direct
1.3K shares at avg. $7.45$10K
HCWB
HCW Biologics Inc.
May 8, 2025
Purchase(P)
Direct
2.3K shares at avg. $26.00$60K
HCWB
HCW Biologics Inc.
May 7, 2025
Purchase(P)
Common Stock Purchase Warrant
Direct
1.2K shares-
LNSR
LENSAR, Inc.
Sep 3, 2024
Purchase(P)
Direct
685 shares at avg. $4.50$3K

		Type	Shares	Price		Ownership
Jun 3, 2026	LNSR LENSAR, Inc.	Award(A)	17,421	-	$0	Direct
May 23, 2025	LNSR LENSAR, Inc.	Award(A)	7,374	-	-	Direct
May 16, 2025	HCWB HCW Biologics Inc.	Purchase(P)	1,342	$7.45	$9,998	Direct
May 8, 2025	HCWB HCW Biologics Inc.	Purchase(P)	2,308	$26.00	$60,008	Direct
May 7, 2025	HCWB HCW Biologics Inc.	Purchase(P) Common Stock Purchase Warrant	1,154	-	-	Direct
Sep 3, 2024	LNSR LENSAR, Inc.	Purchase(P)	685	$4.50	$3,083	Direct

1-6 of 6 transactions

About Winer Gary M

Winer Gary M (SEC CIK 0001822095) files insider reports with the SEC as Director of LENSAR, Inc. (LNSR) and Director of HCW Biologics Inc. (HCWB).

Signal8 holds 5 ownership filings by Winer Gary M, all Form 4s, filed between Sep 6, 2024 and Jun 5, 2026. Those filings report 6 transactions, from Sep 3, 2024 to Jun 3, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Winer Gary M's filings is in ORLANDO, FL.

Recent filings by Winer Gary M

Jun 3, 2026: Grant or award of LNSR shares (Form 4, code A).
May 23, 2025: Grant or award of LNSR shares (Form 4, code A).
May 16, 2025: Open-market purchase of HCWB shares (Form 4, code P).
May 8, 2025: Open-market purchase of HCWB shares (Form 4, code P).
May 7, 2025: Open-market purchase of HCWB derivative securities (Form 4, code P).

Other insiders filing for LENSAR, Inc. (LNSR)

HAMMER TODD B, Director
ELLIS THOMAS B, Director
Wong Kendra, Principal Accounting Officer
Connaughton Alan B., Chief Operating Officer
CURTIS NICHOLAS T, Chief Executive Officer
WEISNER AIMEE S, Director

How to read Form 4 transaction codes